Center-Authored Papers

Filters: Keyword is Anticoagulants  [Clear All Filters]
K
Khorana AA, Streiff MB, Farge D, Mandala M, Debourdeau P, Cajfinger F, Marty M, Falanga A, Lyman GH.  2009.  Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(29):4919-26. Abstract
Kuderer NM, Khorana AA, Lyman GH, Francis CW.  2007.  A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.. Cancer. 110(5):1149-61. Abstract
L
Lyman GH.  2012.  The incidence of venous thromboembolism in cancer patients: a real-world analysis.. Clinical advances in hematology & oncology : H&O. 10(1):40-2.
Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW et al..  2015.  Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(6):654-6. Abstract
Lyman GH.  2011.  Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis.. Cancer. 117(7):1334-49. Abstract
Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H et al..  2007.  American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(34):5490-505. Abstract
Lyman GH, Khorana AA.  2009.  Cancer, clots and consensus: new understanding of an old problem.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(29):4821-6.
Lyman GH, Kuderer NM.  2010.  Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines.. Thrombosis research. 125 Suppl 2:S120-7.
Lyman GH.  2009.  Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer.. Cancer. 115(24):5637-50. Abstract
Lyman GH, Khorana AA, Kuderer NM, Lee AY.  2009.  Cancer and thrombosis: back to the future renewed interest in an old problem.. Cancer investigation. 27(5):472-3. Abstract
R
Roth JA, Boudreau D, Fujii MM, Farin FM, Rettie AE, Thummel KE, Veenstra DL.  2014.  Genetic risk factors for major bleeding in patients treated with warfarin in a community setting.. Clinical pharmacology and therapeutics. 95(6):636-43. Abstract
W
Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W et al..  2008.  Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(8):716-53.